Forget what your state’s law says on paper. NORML’s new Cannabis Freedom Survey asks the question that actually matters: how free do you feel?
Laws on the books and lived reality are two different things. You can be in a legal state and still worry about your job, your landlord, your custody arrangement or a cop who hasn’t gotten the memo. You can be in a prohibited state and have easier access to cannabis than someone paying dispensary prices two states over.
That gap between legal status and actual freedom is exactly what NORML is trying to measure with their 2026 Cannabis Freedom Survey, and they need cannabis consumers to weigh in before 4/20.
The survey takes about a minute. It asks how free you actually feel, not what your state’s policy technically allows. How easy is it to legally buy where you live? How concerned are you about legal consequences? What single reform would make the biggest difference in your day-to-day life?
Those are the questions that matter right now, in a political climate where federal rescheduling is stalled, enforcement priorities are shifting and the rights consumers thought they had are looking less certain than they did a year ago.
Your answers get added to a national snapshot of where cannabis consumers actually stand. The results will be used by NORML heading into 4/20 to show policymakers, press and the public what the community is thinking and feeling in real time.
Take the 2026 NORML Cannabis Freedom Survey here: norml.org/2026-norml-cannabis-freedom-survey
<p>The post How Free Do You Actually Feel as a Cannabis Consumer? NORML Wants to Know first appeared on High Times.</p>
Cannabis can make ideas feel unusually profound by loosening self-criticism, everyday logic and the mental…
Teen cannabis use has fallen across three national surveys while legal markets have opened. At…
A new collaboration brings together iconic functional glass, carefully selected cannabis genetics and a mission…
This interview by Micah Johnson originally appeared in High Times Local, produced under license by…
Congress's watchdog confirmed the DEA has no complete written procedures for drug scheduling. Learn why…
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…